Guardant Health Inc
(MIL:1GH)
€
153.44
+3.46 (+2.31%)
Market Cap: 20.34 Bil
Enterprise Value: 20.90 Bil
PE Ratio: 0
PB Ratio: 0
GF Score: 44/100 Guardant Health Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 15, 2026 / 11:45AM GMT
Release Date Price:
€149.98
(+7.02%)
Kallum Titchmarsh
Morgan Stanley & Co Ltd - Analyst
I think we can get started. Kallum Titchmarsh here from the Life Sciences team at Morgan Stanley. Welcome to day two of the Morgan Stanley Healthcare Conference. Really pleased today to be joined by the team at Guardant Health. We have AmirAli Talasaz, Co-CEO; and Mike Bell, CFO. Thank you, both, for being here.
Amirali Talasaz
Guardant Health, Inc. - Co-Chief Executive Officer, Director
Thanks for having us.
Questions & Answers
Kallum Titchmarsh;Amirali Talasaz
Morgan Stanley & Co Ltd - Analyst;Guardant
Before we get started, just for disclosure relating to this discussion, please see morganstanley.com/researchdisclosures.
So lots of discuss. We've had quite a bit of recent news since those Q2 results, but maybe we can just rehash that Q2, very strong performance across the board. Would love a little state of the union on Guardant Health to kick off, and then we can go into some specifics from there.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot